Thrombosis and cachexia in cancer: Two partners in crime?
- 13 April 2023
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 186, 103989
Abstract
No abstract availableKeywords
Funding Information
- European Social Fund Plus
- Ministério da Ciência, Tecnologia e Ensino Superior
- Faculty of Science and Engineering, University of Manchester
- Fundação para a Ciência e a Tecnologia
This publication has 166 references indexed in Scilit:
- NF-κB–mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexiaJournal of Clinical Investigation, 2013
- Crizotinib versus Chemotherapy in AdvancedALK-Positive Lung CancerNew England Journal of Medicine, 2013
- “Iron-saturated” bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in miceBMC Cancer, 2012
- Incidence and predictors of venous thromboembolism (VTE) among ambulatory high‐risk cancer patients undergoing chemotherapy in the United StatesCancer, 2012
- P‐selectin genotype is associated with the development of cancer cachexiaEMBO Molecular Medicine, 2012
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- Chronic kidney disease and venous thromboembolism: epidemiology and mechanismsCurrent Opinion in Pulmonary Medicine, 2009
- Monocyte Chemoattractant Protein-1 (MCP-1): An OverviewJournal of Interferon & Cytokine Research, 2009
- Trousseau's syndrome: multiple definitions and multiple mechanismsBlood, 2007
- Antimetastatic effects associated with platelet reduction.Proceedings of the National Academy of Sciences, 1968